targetfre
approach
appli
discov
antiinfluenza
viral
compound
influenza
infect
madindarbi
canin
kidney
cell
treat
differ
small
organ
chemic
individu
reduct
virusinduc
cytopath
effect
measur
one
hit
compound
z
halfmaxim
effect
concentr
lm
influenza
b
virus
without
cellular
toxic
lm
investig
structureact
relationship
two
dozen
hit
analog
synthes
among
antiinfluenza
viral
activ
compar
superior
initi
hit
antiinfluenza
viral
compound
effici
suppress
viral
protein
level
infect
cell
also
product
viral
progeni
cultur
supernat
dosedepend
manner
base
modeofact
studi
affect
viru
entri
rna
replic
instead
suppress
viral
neuraminidas
activ
studi
first
demonstr
dihydrofuropyridinon
could
serv
lead
compound
discoveri
altern
influenza
viru
inhibitor
along
season
influenza
vaccin
antivir
play
critic
role
control
influenza
viru
infect
transmiss
import
viral
strain
neutral
exist
vaccin
emerg
occur
pandem
miller
et
al
two
class
antivir
approv
prevent
treat
influenza
first
one
compris
adamantan
includ
amantadin
amt
rimantadin
inhibit
ion
channel
function
influenza
viru
matrix
protein
requir
endosom
acidif
viru
entri
step
da
de
clercq
pinto
et
al
howev
despit
high
efficaci
adamantan
longer
recommend
treatment
influenza
infect
due
high
preval
drug
resist
among
circul
season
influenza
virus
belsh
et
al
saito
et
al
exampl
republ
korea
frequenc
amt
resist
season
influenza
pandem
viru
cho
et
al
second
class
neuraminidas
na
inhibitor
oseltamivir
zanamivir
peramivir
laninamivir
da
de
clercq
samson
et
al
von
itzstein
suppress
na
activ
requir
cleavag
neuramin
acid
moieti
cellular
receptor
glycoprotein
newli
synthes
influenza
virion
antivir
shown
highli
effect
current
circul
influenza
virus
thu
recommend
come
influenza
season
fact
virus
suscept
oseltamivir
zanamivir
respect
season
cdc
howev
accord
earlier
surveil
studi
virus
reduc
oseltamivir
suscept
japan
republ
korea
respect
season
baranovich
et
al
choi
et
al
moreov
leang
et
al
na
mutat
increas
australia
compar
first
year
pandem
sporad
appear
oseltamivir
resist
season
influenza
virus
prompt
note
caution
potenti
pandem
situat
caus
na
inhibitorresist
human
influenza
viru
high
pathogen
transmiss
thu
develop
novel
antivir
agent
overcom
resist
issu
firstlin
antivir
drug
could
worthwhil
pursu
urgent
current
antivir
research
tri
develop
second
gener
antivir
design
na
inhibitor
induc
format
stabil
coval
intermedi
na
target
viral
protein
cellular
protein
involv
viru
replic
da
kim
et
al
laboratori
chemic
librari
approxim
small
organ
compound
screen
discov
hit
compound
activ
two
human
influenza
virus
one
influenza
b
viru
cell
culturebas
system
among
hit
compound
viru
growth
inhibit
lm
z
methylen
one
prove
inhibitori
three
isol
fig
b
studi
aim
investig
structureact
relationship
sar
analog
antivir
modeofact
ultim
provid
insight
design
anoth
class
influenza
inhibitor
uniqu
chemic
structur
differ
exist
antivir
madindarbi
canin
kidney
mdck
cell
african
green
monkey
kidney
vero
cell
purchas
american
type
cultur
collect
atcc
rockvil
md
cell
maintain
minimum
essenti
medium
mem
invitrogen
carlsbad
ca
supplement
fetal
bovin
serum
fb
invitrogen
dulbecco
modifi
eagl
medium
dmem
invitrogen
supplement
fb
respect
co
human
influenza
virus
apuerto
ahong
purchas
atcc
ahong
virus
amplifi
infect
chicken
egg
wherea
tissu
cultureadapt
strain
done
infect
mdck
cell
serumfre
mem
contain
lgml
tpcktrypsin
sigma
st
loui
mo
incub
day
virus
harvest
infect
viru
infect
three
differ
type
influenza
virus
apuerto
ahong
treat
serial
dilut
cell
cultur
media
day
pi
cell
viabil
measur
use
mtt
assay
viabil
uninfect
dmsotreat
cell
set
cell
infect
viru
set
data
shown
mean
standard
deviat
sd
two
sampl
three
independ
experi
nd
detect
c
synthesi
scheme
chemic
methyl
ph
phenyl
egg
allanto
fluid
cell
cultur
supernat
centrifug
rpm
min
store
addit
cell
line
viral
strain
use
antivir
assay
follow
vero
cell
infect
herp
simplex
viru
type
strain
f
type
strain
ms
purchas
atcc
crandel
felin
kidney
crfk
cell
infect
felin
coronaviru
fecv
strain
wsu
atcc
hela
cell
infect
coxsacki
viru
strain
strain
nanci
atcc
cell
infect
human
immunodefici
viru
type
strain
iiib
type
rod
obtain
nation
institut
biolog
standard
control
nibsc
potter
bar
unit
kingdom
amt
ribavirin
rbv
egcg
obtain
sigma
oseltamivir
carboxyl
osvc
us
biolog
swampscott
favipiravir
synthes
inhous
dr
iy
lee
accord
publish
method
furuta
et
al
four
core
scaffold
design
synthes
prepar
deriv
fig
supplementari
data
core
compound
prepar
explor
posit
x
base
previou
report
lena
et
al
use
modif
method
core
compound
synthes
subsequ
dihydrofuropyridinon
prepar
use
method
describ
synthesi
scheme
fig
convent
microwav
heat
condit
use
depend
reactiv
core
scaffold
aldehyd
structur
purifi
compound
confirm
mhz
nmr
bruker
avanc
bruker
biospin
fremont
ca
liquid
chromatographymass
spectrometri
lc
ms
lcm
analysi
perform
use
water
photodiod
array
detector
water
micromass
zq
electrospray
ioniz
posit
ion
mode
water
milford
tabl
puriti
prepar
compound
estim
mdck
cell
seed
plate
either
mockinfect
infect
influenza
virus
multipl
infect
moi
h
remov
medium
cell
treat
test
control
compound
threefold
serial
dilut
serumfre
mem
contain
lgml
tpcktrypsin
day
postinfect
pi
cell
viabil
measur
use
bromid
mtt
sigma
describ
previous
kao
et
al
modif
brief
cell
monolay
incub
mgml
mtt
mem
h
treat
mtt
solvent
n
hcl
triton
isopropanol
shake
plate
min
absorb
read
nm
refer
filter
nm
use
spectramax
micropl
reader
molecular
devic
sunnyval
ca
cytotox
concentr
cc
effect
concentr
ec
valu
calcul
use
graphpad
prism
graphpad
softwar
la
jolla
ca
select
index
si
calcul
ratio
cc
ec
antivir
assay
virus
hsv
de
logu
et
al
fecv
liu
et
al
coxb
zhong
et
al
hiv
bedoya
et
al
malpani
et
al
perform
accord
method
use
mtt
mention
shorter
incub
period
mtt
h
mdck
cell
plate
infect
viru
moi
presenc
dimethyl
sulfoxid
dmso
use
vehicl
dissolv
test
compound
differ
concentr
chemic
cell
cultur
supernat
harvest
h
pi
fifti
microlit
twofold
serial
dilut
viruscontain
supernat
mix
volum
chicken
red
blood
cell
rbc
min
room
temperatur
rt
ha
activ
determin
measur
dilut
factor
sampl
requir
complet
hamedi
chicken
rbc
agglutin
kim
et
al
experi
perform
three
time
duplic
mdck
cell
infect
viru
moi
presenc
test
control
compound
h
determin
infecti
viru
titer
use
plaqu
format
assay
cultur
supernat
tenfold
serial
dilut
mem
infect
fresh
mdck
cell
plate
h
wash
phosphatebuff
salin
pb
cell
incub
overlay
medium
mem
contain
carboxymethylcellulos
cmc
sigma
lgml
tpcktrypsin
plate
incub
day
temperatur
viral
plaqu
visual
stain
crystal
violet
kim
et
al
influenza
viral
rna
extract
cultur
supernat
use
qiaamp
viral
rna
kit
qiagen
hilden
germani
revers
transcrib
cdna
use
superscript
iii
revers
transcriptas
invitrogen
influenza
viral
rnaspecif
univers
primer
hoffmann
et
al
quantit
pcr
perform
use
nsspecif
primer
nsfwd
c
nsrev
cctcttagggattt
kim
et
al
ssofast
evagreen
supermix
biorad
hercul
ca
realtim
pcr
detect
system
biorad
viral
rna
level
virusinfect
cell
defin
rel
viral
rna
level
test
sampl
automat
calcul
use
biorad
cfx
manag
softwar
data
standard
deviat
determin
two
independ
experi
triplic
mdck
cell
plate
inocul
moi
presenc
dmso
vehicl
control
test
compound
lm
osvc
lm
h
cultur
medium
remov
cell
lyse
mammalian
protein
extract
reagent
pierc
biotechnolog
rockford
il
protein
lysat
separ
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
electrotransf
polyvinyliden
difluorid
membran
millipor
billerica
viral
nucleoprotein
np
ha
protein
cellular
bactin
protein
load
control
detect
antinp
catalog
sino
biolog
beij
china
catalog
sino
biolog
bactin
antibodi
catalog
sigma
respect
horseradish
peroxidas
hrp
conjug
secondari
antibodi
goat
antimous
igg
antinp
antibactin
goat
antirabbit
igg
purchas
thermo
scientif
waltham
bound
antibodi
detect
use
supersign
west
pico
chemiluminesc
substrat
detect
kit
thermo
scientif
rockford
il
viru
infect
mdck
cell
seed
fourwel
chamber
slide
moi
absenc
presenc
chemic
lm
incub
h
cell
fix
paraformaldehyd
permeabil
triton
block
normal
goat
serum
bovin
serum
albumin
pb
slide
incub
overnight
influenza
npspecif
monoclon
antibodi
catalog
santa
cruz
biotechnolog
santa
cruz
ca
subsequ
label
alexa
fluor
goat
antimous
igg
invitrogen
h
rt
follow
counterstain
vectashield
mount
medium
contain
dapi
vector
laboratori
burlingam
ca
laser
scan
confoc
microscopi
perform
zeiss
lsm
confoc
microscop
carl
zeiss
thornwood
ny
base
previou
method
dna
sampl
deriv
four
genom
rna
ie
pa
np
clone
individu
vector
harbor
converg
rna
polymeras
ii
promot
rtpcr
gener
pa
np
respect
hoffmann
et
al
hoffmann
et
al
kim
et
al
plasmid
express
influenza
viruslik
rna
firefli
luciferas
fluc
flank
untransl
region
utr
ns
gene
control
human
rna
polymeras
promot
construct
describ
previous
fujii
et
al
kim
et
al
pleschka
et
al
determin
effect
test
compound
influenza
viral
polymeras
activ
vero
cell
cell
per
well
plate
transfect
four
viral
polymerasesnpencod
pvp
dna
lg
togeth
lg
phlrcmv
promega
madison
wi
express
renilla
luciferas
rluc
use
lipofectamin
invitrogen
h
supernat
replac
fresh
medium
contain
dmso
neg
control
increas
amount
compound
day
posttransfect
fluc
activ
measur
normal
rluc
activ
use
dualluciferas
report
assay
system
promega
na
assay
perform
use
naxtd
influenza
neuraminidas
assay
kit
appli
biosystem
foster
citi
ca
accord
manufactur
protocol
modif
murtaugh
et
al
brief
influenza
viru
refer
na
structur
molecular
dock
analysi
na
bind
obtain
protein
data
bank
pdb
access
show
structur
viral
na
complex
osvc
vavricka
et
al
charmm
forc
field
paramet
first
assign
na
protein
bind
site
defin
use
advanc
defin
edit
bind
site
tool
dock
calcul
carri
use
ligandfit
softwar
interfac
accelri
discoveri
studio
accelri
softwar
inc
san
diego
ca
venkatachalam
et
al
detail
ligand
load
protein
bind
site
lowenergi
conform
use
protocol
gener
conform
discoveri
studio
verifi
reliabl
simul
protocol
perform
selfdock
analysi
use
osvc
refer
antivir
compound
base
paramet
use
osvc
silico
dock
osvc
bind
site
within
na
protein
statist
signific
differ
evalu
anova
follow
pairwis
comparison
recommend
anova
analysi
p
consid
signific
cell
culturebas
screen
system
establish
influenza
b
virus
ie
ahong
use
mttbase
cpe
reduct
assay
control
antivir
compound
includ
amt
known
inact
kim
et
al
malpani
et
al
osvc
rbv
sensit
differ
virus
measur
confirm
reliabl
assay
tabl
screen
chemic
librari
small
organ
compound
obtain
korea
chemic
bank
krict
daejeon
republ
korea
observ
one
hit
compound
effici
protect
cell
influenza
viru
infect
fig
b
ec
valu
rang
lm
toxic
mdck
cell
lm
tabl
cpe
reduct
assay
perform
determin
antivir
activ
synthes
compound
use
bicycl
r
initi
fig
tabl
base
result
similar
activ
suggest
replac
sulfur
x
oxygen
still
maintain
antivir
activ
howev
antivir
activ
abolish
indic
nonsubstitut
hydrogen
r
link
posit
indol
substitu
play
signific
role
activ
methyl
group
r
replac
phenyl
group
ec
valu
increas
twoto
threefold
compar
remov
indol
group
led
complet
loss
antivir
activ
interestingli
indol
group
r
substitut
benzo
b
without
fluorid
yield
respect
compound
activ
addit
show
link
posit
either
bicycl
substitu
might
critic
factor
antivir
activ
howev
deriv
b
r
sever
loss
inhibitori
function
indic
introduct
methyl
group
close
link
posit
r
unfavor
taken
togeth
data
suggest
sulfur
oxygen
accept
x
wherea
substitut
hydrogen
r
methyl
group
methyl
group
r
phenyl
group
desir
maintain
antivir
activ
furthermor
optim
bicycl
substitu
appear
unsubstitut
benzo
b
thiophen
explor
sar
r
posit
varieti
compound
prepar
monocycl
r
substitu
fig
tabl
antivir
activ
substitu
r
improv
threefold
compar
ec
valu
lm
toxic
uninfect
mdck
cell
lm
threeto
fivefold
activ
bicycl
cognat
indic
monocycl
thiophen
could
suitabl
substitu
bicycl
benzo
b
thiophen
r
evalu
substitut
effect
x
r
posit
keep
r
r
intact
oxygen
x
phenyl
r
prepar
respect
exhibit
signific
toxic
cc
valu
lm
antivir
activ
except
ahong
strain
replac
thiophen
furan
result
threeto
fivefold
less
activ
compound
oxygen
version
x
also
toxic
cc
lm
inact
found
compound
imidazol
r
show
antiinfluenza
activ
even
lm
monocycl
r
version
compar
ec
valu
rang
lm
three
influenza
virus
test
contrast
phenyl
r
version
still
activ
ec
valu
lm
although
less
potent
investig
whether
modif
thiophen
ring
contribut
influenza
inhibitori
effect
monocycl
compound
addit
seri
deriv
synthes
antivir
activ
test
addit
methyl
group
posit
posit
thiophen
yield
compar
antivir
activ
notabl
monocycl
r
version
far
activ
substitut
ethyl
group
posit
activ
reduc
inhibitor
effect
howev
addit
electronwithdraw
bromid
posit
thiophen
decreas
nullifi
antivir
effect
tabl
show
methyl
r
result
loss
antivir
activ
bicycl
substitu
contrast
methyl
group
r
monocycl
substitu
maintain
antivir
activ
like
r
unmethyl
taken
togeth
result
suggest
antiinfluenza
viral
activ
maintain
substitut
bicycl
r
monocycl
thiophen
furan
ring
imidazol
ring
alkyl
bromid
substitut
r
indic
addit
electrondon
group
appear
prefer
electronwithdraw
group
improv
antivir
activ
contrast
bicycl
compound
introduct
sulfur
x
posit
monocycl
deriv
desir
oxygen
reduc
toxic
wherea
substitut
hydrogen
methyl
group
r
affect
antivir
activ
particularli
seven
activ
compound
includ
show
si
valu
tabl
howev
calcul
exact
si
avail
dmsoderiv
cytotox
concentr
higher
lm
contain
dmso
addit
use
three
repres
activ
compound
mttbase
antivir
efficaci
test
perform
addit
cell
lysisinduc
virus
hsv
fecv
coxb
hiv
howev
antivir
activ
detect
maximum
concentr
lm
virus
data
shown
indic
antivir
activ
mention
influenza
virusspecif
base
result
cpe
reduct
assay
tabl
seven
compound
appli
addit
antivir
assay
mdck
cell
incub
presenc
increas
amount
test
compound
well
control
compound
osvc
ha
titer
cultur
supernat
first
measur
h
interv
h
pi
tabl
dmsotreat
control
sampl
ha
titer
detect
h
pi
data
shown
howev
reach
ha
unit
hau
per
cultur
supernat
h
pi
respect
show
maximum
h
pi
expect
consider
reduct
ha
titer
sampl
treat
lm
osvc
result
hau
detect
even
h
pi
among
test
sampl
potent
inhibitor
exhibit
dosedepend
inhibitori
respons
whole
detect
period
other
also
exhibit
dosedepend
activ
earli
time
point
ie
h
pi
unabl
suppress
viral
replic
thereaft
concentr
lm
follow
studi
design
address
whether
three
activ
compound
could
inhibitori
effect
infecti
viru
yield
thu
viru
titrat
plaqu
assay
quantit
rtpcr
analys
consist
result
ha
assay
tabl
significantli
inhibit
level
infecti
viral
titer
fig
vrna
level
fig
dosedepend
use
mdck
cell
effect
antivir
compound
express
level
viral
protein
addit
studi
use
western
blot
analysi
fig
overal
result
suggest
antivir
compound
among
synthes
dihydrofuropyridinon
inhibitori
effect
infecti
influenza
viru
product
viral
protein
express
confoc
microscopi
perform
determin
whether
viru
entri
step
target
antivir
dihydrofuropyridinon
h
pi
allow
viral
adsorpt
penetr
intracellular
local
viral
np
protein
analyz
presenc
lm
egcg
influenza
viru
entri
inhibitor
fig
show
egcg
reduc
overal
np
signal
intens
cell
kim
et
al
contrast
np
distribut
intens
cell
affect
similar
dmso
control
result
suggest
effect
viru
entri
examin
involv
viral
rna
replic
influenza
polymeras
activ
assay
system
introduc
influenza
viruslik
rna
contain
fluc
serv
report
gene
result
clearli
show
viral
rna
polymeras
function
vero
cell
chang
wherea
suppress
influenza
viral
polymeras
inhibitor
fig
data
suggest
antivir
target
dihydrofuropyridinon
compound
probabl
could
late
step
viral
rna
replic
protein
np
ha
detect
use
specif
primari
antibodi
hrpconjug
secondari
antibodi
cellular
bactin
use
load
control
protein
indic
arrow
right
panel
triangl
top
indic
increas
chemic
concentr
examin
whether
antivir
dihydrofuropyridinon
could
affect
final
step
viru
progeni
releas
infect
cell
na
inhibitori
activ
assess
use
whole
influenza
virion
notabl
suppress
na
activ
ic
valu
lm
lm
respect
wherea
inact
cpe
reduct
assay
tabl
fig
find
also
appear
viral
strain
ahong
data
shown
addit
base
previou
report
vavricka
et
al
silico
molecular
dock
analysi
perform
use
ligand
na
protein
conform
fit
activ
site
na
protein
via
interact
amino
acid
fig
indol
part
form
cationp
interact
fluorin
indol
found
involv
weak
hydrogen
bond
explain
reason
complet
loss
activ
tabl
notabl
hydrogen
r
posit
core
skeleton
made
hydrogen
bond
accord
observ
similar
structur
antivir
activ
success
load
activ
site
na
data
shown
howev
inact
methyl
compound
posit
fail
stabli
load
confirm
suppress
function
oseltamivirresist
na
protein
na
effici
wildtyp
na
deriv
influenza
fig
taken
togeth
data
suggest
antivir
activ
dihydrofuropyridinon
express
occupi
activ
site
within
na
therebi
block
enzymat
activ
present
studi
screen
chemic
librari
small
organ
compound
deposit
krict
chemist
identifi
dihydrofuropyridinon
compound
inhibit
influenza
b
viru
replic
cell
ec
valu
lm
cc
lm
fig
tabl
chemic
synthesi
deriv
facilit
investig
sar
improv
antivir
efficaci
result
also
found
activ
use
addit
antivir
assay
measur
titer
viru
multipl
infect
moi
presenc
dmso
lm
egcg
h
viral
np
protein
detect
confoc
microscopi
use
npspecif
monoclon
antibodi
alexa
goat
antimous
secondari
antibodi
green
nuclei
counterstain
dapi
blue
origin
magnif
b
vero
cell
transfect
four
pvp
dna
express
polymerasenp
protein
phhfluc
phrlcmv
transfect
control
h
dmso
increas
amount
lm
dmem
fb
ad
well
fluc
express
level
cell
measur
normal
rluc
day
interpret
refer
color
figur
legend
reader
refer
web
version
articl
ha
infecti
viral
particl
viral
rna
cultur
supernat
well
viral
protein
level
cell
lysat
ensur
could
suppress
product
infecti
influenza
virus
tabl
fig
previous
relationship
structur
dihydrofuropyridinon
inhibitori
effect
cell
lysi
induc
poreform
glycoprotein
perforin
investig
lena
et
al
howev
consensu
chemic
structur
abil
inhibit
perforininduc
cytolyt
effect
suppress
influenza
viru
replic
exampl
activ
wherea
inact
studi
contrast
exhibit
antivir
activ
present
studi
none
previou
studi
lena
et
al
exclud
possibl
antiinfluenza
activ
dihydrofuropyridinon
gain
intrins
properti
improv
cell
viabil
nonspecif
repeat
mttbase
antivir
assay
cell
lysisinduc
virus
hsv
fecv
coxb
hiv
howev
antiinfluenza
viral
compound
fail
show
antivir
function
data
shown
indic
antivir
activ
influenza
virusspecif
furthermor
modeofact
studi
silico
dock
analysi
activ
compound
suggest
antivir
effect
may
occur
late
stage
particularli
namedi
viru
releas
step
step
viru
entri
viral
rna
replic
fig
conclus
result
present
studi
suggest
dihydrofuropyridinon
signific
antiinfluenza
viral
activ
cell
main
modeofact
inhibit
viral
na
activ
thu
anticip
compound
provid
initi
chemic
structur
develop
nonsial
acidbas
na
inhibitor
facilit
design
novel
antiinfluenza
drug
